Xenetic Biosciences Inc Sustainability Reports
Xenetic Biosciences, Inc. is a biopharmaceutical company focused on advancing oncology therapeutics. The company utilizes its proprietary DNase platform to target neutrophil extracellular traps (NETs) and improve the efficacy of existing cancer treatments.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 5493002WV0KYX8JXAH52
FIGI: BBG0028WJY38
5 reports from 2013 to 2023